Immunohistochemical expression of CD44v6 in differentiated thyroid carcinomasFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 24 May 2012

References

• J.K.C.ChanM.HirokawaH.EvansE.D.WilliamsY.OsamuraB.CadyR.A.DeLellisR.V.LloydP.U.HeitzC.EngWHO classification of tumours: pathology, genetics of tumours of endocrine organs2004IARC PressLyon, Francep.98–103
   Google Scholar
• National Cancer Institute, Cairo University, Egypt. Cancer Registry 2002–2003. NCI 2002-03: 1–75.
   Google Scholar
• H.PontaL.ShermanP.A.HerrlichCD44: from adhesion molecules to signalling regulatorsNature Rev Mol Cell Biol420033345
   PubMed Web of Science ®Google Scholar
• G.ErmakG.GerasimovK.TroshinaT.JenningsL.RobinsonJ.S.RossDeregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroidCancer Res55199545944598
   Web of Science ®Google Scholar
• U.GünthertCD44: a multitude of isoforms with diverse functionsCure. Top Microbiol Immunol18419934763
   PubMedGoogle Scholar
• C.UnderhillCD44: the hyaluronan receptorJ Cell Sci1031992293298
   PubMed Web of Science ®Google Scholar
• A.KiziridouA.PantidouC.H.DestouniT.ToliouImmunohistochemical expression of CD44 in thyroid gland lesionsArch Oncol111200358
   Google Scholar
• G.ErmakT.GenningsL.RobinsonJ.S.RossJ.FiggeRestricted patterns of CD44 variant exon expression in human papillary thyroid carcinomaCancer Res56199610371042
   Web of Science ®Google Scholar
• E.DaraiF.Walker-CombrouzeA.FauconnierP.MadelenatF.PotetJ.-Y.ScoazecAnalysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomasHistopathology321998151159
   Web of Science ®Google Scholar
• S.RegauerA.OttBeham.A.BergholdCD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?J Pathol1871999184190
   Web of Science ®Google Scholar
• D.CoppolaM.HyacintheL.FuA.CantorR.KarlJ.MarcetCD44v6 expression in human colorectal carcinomaHum Pathol291998627635
   PubMed Web of Science ®Google Scholar
• D.HudsonP.SpeightF.WattAltered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from themInt J Cancer661996457463
   PubMed Web of Science ®Google Scholar
• V.TomaD.HauriU.SchmidD.AckermannR.MaurerG.AlundFocal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinomaAm J Pathol155199914271432
   PubMed Web of Science ®Google Scholar
• J.P.BöhmL.K.NiskanenR.T.PirinenK.KiralyJ.K.KellokosiKiMoisioReduced CD44 standard expression is associated with tumor recurrence and unfavourable outcome in differentiated thyroid carcinomaJ Pathol1922000321327
   Web of Science ®Google Scholar
• M.A.NoordzijG.J.Van SteenbruggeN.S.VerkaikF.H.SchroderT.H.Van der KwastThe prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomyClin Cancer Res31997805815
   PubMed Web of Science ®Google Scholar
• E.LeslieJ.GeoffreyM.JamesStatistical analysis. Interpretation and uses of medical statistics4th ed.1991Oxford Scientific Publications411416
   Google Scholar
• G.ScreatonM.BellD.JacksonF.CornelisU.GerthJ.BellGenomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exonsProc Natl Acad Sci USA8919921216012164
   PubMed Web of Science ®Google Scholar
• H.PontaD.WainwrightP.HerrlichMolecules in focus. The CD44 protein familyInt J Biochem Cell Biol301998299305
   PubMed Web of Science ®Google Scholar
• J.MarutaH.HashimotoH.YamashitaH.YamashitaS.NoguchiImmunostaining of Galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenomaDiag Cytopathol312004392396
   PubMed Web of Science ®Google Scholar
• J.S.RossA.D.del RosarioB.SandersonH.X.BuiSelective expression of CD44 cell-adhesion molecule in thyroid papillary carcinoma fine-needle aspiratesDiagn Cytopathol141996287291
   Web of Science ®Google Scholar
• D.ChhiengJ.RossB.McKennaCD44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear grooves and inclusionsCancer Cytopathol811997157162
   Web of Science ®Google Scholar
• A.BartolazziA.GasbarriM.PapottiG.BussolatiT.LucanteA.KhanApplication of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesionsLancet357200116441650
   PubMed Web of Science ®Google Scholar
• S.FischerS.L.AsaApplication of Immunohistochemistry to Thyroid NeoplasmsArch Pathol Lab Med1322008359372
   PubMed Web of Science ®Google Scholar
• L.LiL.LinJ.QiuExpression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance [abstract]Zhonghua Nei Ke Zhi40102001677680
   Google Scholar
• M.K.McLeodM.E.EastR.E.BurneyJ.K.HarnessN.W.ThompsonHashimoto's thyroiditis revisited: the association with thyroid cancer remains obscureWorld J Surg121988509516
   Web of Science ®Google Scholar
• Pazaitou-Panayiotou K, Mygdakos N, Boglou K, kiziridou A, Chrisoulidou A, Destouni C. The immunocytochemistry is a valuable tool in the diagnosis of papillary thyroid cancer in FNA's using liquid-based cytology. J Oncology doi:10.1155/2010/963926.
   Google Scholar
• Hamam SM, Ahmed KS, Younis LK, El- Kayal SA, Hassan M. In vitro expression of CD44 v6 in non-metastatic and metastatic colorectal carcinoma. Honours (thesis) Alexandria: Alexandria University;1999.
   Google Scholar
• S.J.WangG.WongA.M.de HeerW.XiaL.Y.W.BourguignonCD44 variant isoforms in head and neck squamous cell carcinoma progressionLaryngoscope119200915181530
   PubMed Web of Science ®Google Scholar
• W.K.F.SeelentagU.GünthertP.SaremaslanE.futoM.PfaltzP.U.HeitzCD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and de-differentiationInt J Cancer (Pred. Oncol.)691996218224
   Web of Science ®Google Scholar
• V.A.LiVolsiPapillary neoplasms of the thyroid. Pathologic and prognostic featuresAm J Clin Pathol971992426434
   PubMed Web of Science ®Google Scholar
• U.GünthertM.HofmannW.RudeyS.ReberM.ZöllerI.HaussmannA new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell6519911324
   PubMed Web of Science ®Google Scholar
• R.ArchK.WirthM.HofmannH.PontaS.MtzkuP.HerrlichParticipation in normal immune responses of a metastasis-inducing splice variant of CD44Science2571992682685
   PubMed Web of Science ®Google Scholar
• J.GuT.DaaK.KashimaS.YokoyamaI.NakayamaS.NoguchiExpression of splice variant of CD44 in thyroid neoplasms derived from follicular cellsPathol Int481998184190
   Web of Science ®Google Scholar
• A.AfifyL.C.LynneL.HowellCorrelation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusionsDiagn Cytopathol352007105110
   Web of Science ®Google Scholar
• M.KajitaY.ItohT.ChibaH.MoriA.OkadaH.KinohMembrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migrationJCB15352001893904
   PubMed Web of Science ®Google Scholar
• K.N.SugaharaT.HirataH.HayasakaR.SternT.MuraiM.MiyasakaTumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragmentsJ Biol Chem2819200658615868
   PubMed Web of Science ®Google Scholar
• H.MatsukiK.YonezawaK.ObataK.IwataH.NakamuraY.OkadaMonoclonal antibodies with defined recognition sequences in the stem region of CD44 detection of differential glycosylation of CD44 between tumor and stromal cells in tissueCancer Res63200382788283
   Web of Science ®Google Scholar
• A.GasbarriM.P.MarteganiF.Del PreteT.LucanteP.G.NataliA.BartolazziGalectin-3 and CD44v6 isoforms in the preperative evaluation of thyroid nodulesJ Clin Oncol17199934943502
   PubMed Web of Science ®Google Scholar
• F.MackayH.LoetscherD.StueberG.GehrW.LesslauerTumor Necrosis Factor a (TNFa)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55J Exp Med177199312771286
   PubMed Web of Science ®Google Scholar